Global Anticoagulants Market Survey and Trend Research 2018
Summary
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, serum-separating tubes, blood transfusion bags, and dialysis equipment.
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.
Industry Chain
- Raw Materials
- Cost
- Technology
- Consumer Preference
- History
- Development & Trend
- Market Competition
- Trade Overview
- Policy
- Regional Market
- Production Development
- Sales
- Regional Trade
- Regional Forecast
- Company Profile
- Product & Service
- Business Operation Data
- Market Share
- Market Features
- Investment Opportunity
- Investment Calculation
PART 1 INDUSTRY OVERVIEW
1.1 Anticoagulants Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 ANTICOAGULANTS MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Bayer (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Sanofi (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Boehringer Ingelheim (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Johnson & Johnson (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 AstraZeneca (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 AstraZeneca (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Aspen (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Lilly (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Otsuka (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Pfizer (Company Overview, Sales Data etc.)
4.12 Daiichi Sankyo (Company Overview, Sales Data etc.)
4.13 The Medicines Company (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
1.1 Anticoagulants Industry
1.1.1 Definition
1.1.2 Industry Trend
1.2 Industry Chain
1.2.1 Upstream
1.2.2 Technology
1.2.3 Cost Structure
1.2.4 Consumer Preference
1.2.2 Downstream
PART 2 INDUSTRY OVERALL
2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview
PART 3 ANTICOAGULANTS MARKET BY PRODUCT
3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 KEY COMPANIES LIST
4.1 Bayer (Company Overview, Sales Data etc.)
4.1.1 Company Overview
4.1.2 Products and Services
4.1.3 Business Analysis
4.2 Sanofi (Company Overview, Sales Data etc.)
4.2.1 Company Overview
4.2.2 Products and Services
4.2.3 Business Analysis
4.3 Boehringer Ingelheim (Company Overview, Sales Data etc.)
4.3.1 Company Overview
4.3.2 Products and Services
4.3.3 Business Analysis
4.4 Johnson & Johnson (Company Overview, Sales Data etc.)
4.4.1 Company Overview
4.4.2 Products and Services
4.4.3 Business Analysis
4.5 AstraZeneca (Company Overview, Sales Data etc.)
4.5.1 Company Overview
4.5.2 Products and Services
4.5.3 Business Analysis
4.6 AstraZeneca (Company Overview, Sales Data etc.)
4.6.1 Company Overview
4.6.2 Products and Services
4.6.3 Business Analysis
4.7 Bristol-Myers Squibb (Company Overview, Sales Data etc.)
4.7.1 Company Overview
4.7.2 Products and Services
4.7.3 Business Analysis
4.8 Aspen (Company Overview, Sales Data etc.)
4.8.1 Company Overview
4.8.2 Products and Services
4.8.3 Business Analysis
4.9 Lilly (Company Overview, Sales Data etc.)
4.9.1 Company Overview
4.9.2 Products and Services
4.9.3 Business Analysis
4.10 Otsuka (Company Overview, Sales Data etc.)
4.10.1 Company Overview
4.10.2 Products and Services
4.10.3 Business Analysis
4.11 Pfizer (Company Overview, Sales Data etc.)
4.12 Daiichi Sankyo (Company Overview, Sales Data etc.)
4.13 The Medicines Company (Company Overview, Sales Data etc.)
PART 5 MARKET COMPETITION
5.1 Companies Competition
5.2 Industry Competition Structure Analysis
5.2.1 Rivalry
5.2.2 Threat of New Entrants
5.2.3 Substitutes
5.2.4 Bargaining Power of Suppliers
5.2.5 Bargaining Power of Buyers
PART 6 MARKET DEMAND BY SEGMENT
6.1 Demand Situation
6.1.1 Industry Application Status
6.1.2 Industry SWOT Analysis
6.1.2.1 Strengths
6.1.2.2 Weaknesses
6.1.2.3 Opportunities
6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast
PART 7 REGION OPERATION
7.1 Regional Market
7.2 Production and Sales by Region
7.2.1 Production
7.2.2 Sales
7.2.3 Trade
7.3 Regional Forecast
PART 8 MARKET INVESTMENT
8.1 Market Features
8.1.1 Product Features
8.1.2 Price Features
8.1.3 Channel Features
8.1.4 Purchasing Features
8.2 Investment Opportunity
8.2.1 Regional Investment Opportunity
8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
8.3.1 Cost Calculation
8.3.2 Revenue Calculation
8.3.3 Economic Performance Evaluation
PART 9 CONCLUSION
LIST OF TABLES
Table GLOBAL ANTICOAGULANTS MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Anticoagulants Market 2012-2017, by Type, in Volume
Table Global Anticoagulants Market Forecast 2018-2023, by Type, in USD Million
Table Global Anticoagulants Market Forecast 2018-2023, by Type, in Volume
Table Bayer Overview List
Table Anticoagulants Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Anticoagulants Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Anticoagulants Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Anticoagulants Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Anticoagulants Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Anticoagulants Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Anticoagulants Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aspen Overview List
Table Anticoagulants Business Operation of Aspen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Lilly Overview List
Table Anticoagulants Business Operation of Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Otsuka Overview List
Table Anticoagulants Business Operation of Otsuka (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Anticoagulants Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Anticoagulants Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table The Medicines Company Overview List
Table Anticoagulants Business Operation of The Medicines Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Anticoagulants Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Anticoagulants Sales Revenue Share, by Companies, in USD Million
Table Global Anticoagulants Sales Volume 2012-2017, by Companies, in Volume
Table Global Anticoagulants Sales Revenue Share, by Companies in 2017, in Volume
Table Anticoagulants Demand 2012-2017, by Application, in USD Million
Table Anticoagulants Demand 2012-2017, by Application, in Volume
Table Anticoagulants Demand Forecast 2018-2023, by Application, in USD Million
Table Anticoagulants Demand Forecast 2018-2023, by Application, in Volume
Table Global Anticoagulants Market 2012-2017, by Region, in USD Million
Table Global Anticoagulants Market 2012-2017, by Region, in Volume
Table Anticoagulants Market Forecast 2018-2023, by Region, in USD Million
Table Anticoagulants Market Forecast 2018-2023, by Region, in Volume
Table GLOBAL ANTICOAGULANTS MARKET 2012-2017, BY TYPE, IN USD MILLION
Table Global Anticoagulants Market 2012-2017, by Type, in Volume
Table Global Anticoagulants Market Forecast 2018-2023, by Type, in USD Million
Table Global Anticoagulants Market Forecast 2018-2023, by Type, in Volume
Table Bayer Overview List
Table Anticoagulants Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Anticoagulants Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Anticoagulants Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Johnson & Johnson Overview List
Table Anticoagulants Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Anticoagulants Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Anticoagulants Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Anticoagulants Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aspen Overview List
Table Anticoagulants Business Operation of Aspen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Lilly Overview List
Table Anticoagulants Business Operation of Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Otsuka Overview List
Table Anticoagulants Business Operation of Otsuka (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Anticoagulants Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Anticoagulants Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table The Medicines Company Overview List
Table Anticoagulants Business Operation of The Medicines Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Anticoagulants Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Anticoagulants Sales Revenue Share, by Companies, in USD Million
Table Global Anticoagulants Sales Volume 2012-2017, by Companies, in Volume
Table Global Anticoagulants Sales Revenue Share, by Companies in 2017, in Volume
Table Anticoagulants Demand 2012-2017, by Application, in USD Million
Table Anticoagulants Demand 2012-2017, by Application, in Volume
Table Anticoagulants Demand Forecast 2018-2023, by Application, in USD Million
Table Anticoagulants Demand Forecast 2018-2023, by Application, in Volume
Table Global Anticoagulants Market 2012-2017, by Region, in USD Million
Table Global Anticoagulants Market 2012-2017, by Region, in Volume
Table Anticoagulants Market Forecast 2018-2023, by Region, in USD Million
Table Anticoagulants Market Forecast 2018-2023, by Region, in Volume
LIST OF FIGURES
Figure Anticoagulants Industry Chain Structure
Figure Global Anticoagulants Market Growth 2012-2017, by Type, in USD Million
Figure Global Anticoagulants Market Growth 2012-2017, by Type, in Volume
Figure Global Anticoagulants Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Anticoagulants Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
Figure Anticoagulants Industry Chain Structure
Figure Global Anticoagulants Market Growth 2012-2017, by Type, in USD Million
Figure Global Anticoagulants Market Growth 2012-2017, by Type, in Volume
Figure Global Anticoagulants Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Anticoagulants Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region
